Atlas Trials

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Clinical trial NCT05494320 · UNKNOWN

Trial details

NCT number
NCT05494320
Sponsor
Ain Shams University
Status
UNKNOWN
Study type
OBSERVATIONAL
Gastrointestinal Cancer
Start date
2021-08-15
Primary completion
2022-08-05
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.